Please use this identifier to cite or link to this item:
https://doi.org/10.2807/ese.15.42.19692-en
Title: | A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore | Authors: | Barr, I.G Cui, L Komadina, N Lee, R.T Lin, R.T Deng, Y Caldwell, N Shaw, R Maurer-Stroh, S |
Keywords: | influenza vaccine Influenza virus hemagglutinin membrane antigen virus sialidase Influenza virus hemagglutinin virus antigen antigenic variation antigenicity article Australia gene mutation gene sequence genetic drift genetic variability hemagglutination inhibition test human influenza A (H1N1) Influenza virus A H1N1 New Zealand nonhuman pandemic influenza phylogenetic tree seasonal variation sequence analysis sequence homology Singapore single drug dose taxonomic rank viral genetics virus genome virus strain virus virulence winter Australia classification DNA sequence genetics immunology influenza isolation and purification mutation New Zealand pandemic phylogeny season Singapore virology Antigens, Viral Australia Hemagglutinin Glycoproteins, Influenza Virus Humans Influenza A Virus, H1N1 Subtype Influenza, Human Mutation New Zealand Pandemics Phylogeny Seasons Sequence Analysis, DNA Singapore |
Issue Date: | 2010 | Citation: | Barr, I.G, Cui, L, Komadina, N, Lee, R.T, Lin, R.T, Deng, Y, Caldwell, N, Shaw, R, Maurer-Stroh, S (2010). A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore. Eurosurveillance 15 (42) : 1-6. ScholarBank@NUS Repository. https://doi.org/10.2807/ese.15.42.19692-en | Rights: | Attribution 4.0 International | Abstract: | Pandemic H1N1 influenza virus is of global health concern and is currently the predominant influenza virus subtype circulating in the southern hemisphere 2010 winter. The virus has changed little since it emerged in 2009, however, in this report we describe several genetically distinct changes in the pandemic H1N1 influenza virus. These variants were first detected in Singapore in early 2010 and have subsequently spread through Australia and New Zealand. At this stage, these signature changes in the haemagglutinin and neuraminidase proteins have not resulted in significant antigenic changes which might make the current vaccine less effective, but such adaptive mutations should be carefully monitored as the northern hemisphere approaches its winter influenza season. | Source Title: | Eurosurveillance | URI: | https://scholarbank.nus.edu.sg/handle/10635/181687 | ISSN: | 1025496X | DOI: | 10.2807/ese.15.42.19692-en | Rights: | Attribution 4.0 International |
Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_2807_ese_15_42_19692-en.pdf | 1.26 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License